Biocept has appointed Michael Dugan as chief medical officer and medical director, responsible for medical policy decision-making and operations of Biocept's CLIA-certified laboratory. Dugan has more than 25 years of industry experience, most recently as president and CEO of professional advisory group practice MCDXI Medical Diagnostics International. Before that, he was senior medical advisor and chief medical officer of Clinical Genomics. He has also served as senior VP of clinical development and medical affairs at Exact Sciences, medical director at Quest Diagnostics Nichols Institute, chief medical officer at BioTheranostics, VP and chief medical officer at Roche Molecular Systems, and VP of pathology services at Genzyme Genetics.
Dugan received a BS in biology from the University of Notre Dame and a medical degree from the University of Arizona College of Medicine. He completed his post-graduate training in the department of pathology at Yale-New Haven Hospital and in the departments of pathology and laboratory medicine at Childrens Hospital Los Angeles and the University of California, Los Angeles.